Sources: Shein is targeting a $40B+ valuation after winning Beijing's approval for a Hong Kong IPO, set for as early as Q3; Shein canceled its US IPO in 2024
Context & Ripple Effects
Shein’s listing plans have repeatedly moved across markets: from a confidential US IPO filing in 2023, to a UK regulatory filing in 2024, and then toward Hong Kong after it reportedly failed to obtain Chinese regulatory approval for London.
The reported Beijing approval removes the regulatory blockage that had shaped that migration. It also comes after successive reported valuation benchmarks fell from an $80B–$90B US-IPO target to private-market indications around $45B–$55B, making the proposed $40B+ Hong Kong target a more cautious public-market reset.
First-order effects
- Shein can proceed with preparations for a Hong Kong IPO as early as Q3, rather than remaining stalled between its abandoned US plan and delayed London route.
- The company will market a $40B+ valuation target, anchoring prospective investors to a materially lower range than its earlier US IPO ambitions.
Second-order effects
- Hong Kong becomes the operative venue for Shein’s liquidity event, concentrating investor, adviser, and exchange attention on whether the market can absorb one of the company’s long-delayed listings.
- The approval clarifies that Chinese regulatory consent is a gating factor for Shein’s overseas listing strategy; other venue options become less relevant unless the Hong Kong process itself encounters obstacles.
Third-order effects
- If this pattern persists, Chinese-founded global consumer platforms may increasingly treat Hong Kong as the more executable public-listing route when US or UK offerings face regulatory or political friction.
- The valuation trajectory suggests that cross-border listing access and regulatory certainty can weigh as heavily on late-stage company pricing as operating scale, potentially producing more conservative IPO expectations after prolonged delays.
The trend: Shein is one data point in the redirection of Chinese-linked companies’ public-market plans toward Hong Kong as regulatory approval increasingly determines both listing venue and valuation expectations.